You have 9 free searches left this month | for more free features.

everolimus

Showing 26 - 50 of 435

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Renal Cell Carcinoma Trial (Cabozantinib, Ipilimumab, Nivolumab)

Not yet recruiting
  • Renal Cell Carcinoma
  • (no location specified)
Jun 9, 2022

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer Trial in Buffalo, Rochester

Terminated
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Buffalo, New York
  • +1 more
Aug 11, 2022

Breast Cancer Trial in New Haven (Everolimus)

Terminated
  • Breast Cancer
  • Everolimus
  • New Haven, Connecticut
    Yale University
Jan 12, 2022

Advanced Breast Cancer Trial in China (Everolimus, Exemestane, Everolimus Placebo)

Completed
  • Advanced Breast Cancer
  • Everolimus
  • +2 more
  • Guangzhou, Guangdong, China
  • +14 more
Jun 17, 2022

Bladder Cancer, Metastatic Transitional Cell Carcinoma Trial in New York (Everolimus)

Completed
  • Bladder Cancer
  • Metastatic Transitional Cell Carcinoma
  • Everolimus
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Dec 16, 2021

Breast Tumors, Endocrine Breast Diseases, Tumor Metastasis Trial in Baltimore (letrozole, lapatinib, everolimus)

Terminated
  • Breast Neoplasms
  • +2 more
  • Baltimore, Maryland
    University of Maryland Marlene & Stewart Greenebaum Cancer Cente
Feb 9, 2022

Recurrent Endometrial Carcinoma, Recurrent Endometrial Endometrioid Adenocarcinoma, Refractory Endometrial Carcinoma Trial in

Recruiting
  • Recurrent Endometrial Carcinoma
  • +12 more
  • Everolimus
  • +2 more
  • Houston, Texas
  • +1 more
Sep 22, 2022

Solid Tumours, Multiple Myeloma, Lung Cancer Trial in Sutton, London (VS-6766, Everolimus)

Recruiting
  • Solid Tumours
  • +2 more
  • Sutton, Surrey, United Kingdom
  • +1 more
Apr 25, 2022

Carcinoma, Hepatocellular Trial in United States (Everolimus, Tacrolimus, Myfortic)

Active, not recruiting
  • Carcinoma, Hepatocellular
  • Everolimus
  • +4 more
  • San Francisco, California
  • +8 more
Jul 19, 2022

Solid Organ Malignancies, Adenoidcystic Carcinoma, Neuroendocrine Tumors Trial in Atlanta (Lenalidomide, Everolimus)

Completed
  • Solid Organ Malignancies
  • +2 more
  • Atlanta, Georgia
  • +1 more
Nov 19, 2021

Growth and Development Trial in Belgium, Russian Federation, United States (Everolimus, Envirolimus drug class as prescribed by

Active, not recruiting
  • Growth and Development
  • Everolimus
  • Envirolimus drug class as prescribed by Physician
  • Los Angeles, California
  • +5 more
Dec 5, 2022

Neuroendocrine Tumors Trial in Boston, New York, Houston (LEE011, everolimus)

Active, not recruiting
  • Neuroendocrine Tumors
  • Boston, Massachusetts
  • +4 more
Feb 22, 2022

Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer Trial in

Terminated
  • Estrogen Receptor-positive Breast Cancer
  • +7 more
  • everolimus
  • +5 more
  • Atlanta, Georgia
  • +2 more
Mar 10, 2022

High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Anaplastic Astrocytoma Trial in Worldwide (Ribociclib, Everolimus)

Not yet recruiting
  • High Grade Glioma
  • +8 more
  • Aurora, Colorado
  • +17 more
May 2, 2023

Renal Cell Carcinoma Trial in Shanghai (Anlotinib HCl, everolimus)

Not yet recruiting
  • Renal Cell Carcinoma
  • Anlotinib hydrochloride
  • everolimus
  • Shanghai, China
    270 Dongan Road, Fudan University Shanghai Cancer Center
Nov 5, 2021

Advanced Malignant Solid Tumor, EGFR Gene Amplification, EGFR Gene Mutation Trial in Houston (Everolimus, Neratinib,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +9 more
  • Everolimus
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 25, 2022

Low Grade Glioma, World Health Organization (WHO) Grade II Astrocytomas, Oligodendrogliomas Trial in San Francisco (Everolimus,

Terminated
  • Low Grade Glioma
  • +3 more
  • San Francisco, California
    University of California, San Francisco
Nov 3, 2021

Advanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Trial

Recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 17, 2022

Differentiated Thyroid Cancer Trial in Philadelphia (Everolimus, Sorafenib)

Active, not recruiting
  • Differentiated Thyroid Cancer
  • Philadelphia, Pennsylvania
    Hospital of the University of Pennsylvania
Oct 18, 2021

Primary Non-metastatic Breast Cancer, Who Remain Disease-free Trial in Lyon, Villejuif (Everolimus, Placebo)

Active, not recruiting
  • Primary Non-metastatic Breast Cancer
  • Who Remain Disease-free
  • Everolimus
  • Placebo
  • Lyon, France
  • +1 more
Feb 23, 2022

Endometrial Cancer Trial in Pensacola, Voorhees, Houston (Metformin, Letrozole, Everolimus)

Active, not recruiting
  • Endometrial Cancer
  • Pensacola, Florida
  • +5 more
Feb 9, 2022

Neuroendocrine Tumors, Lung Neuroendocrine Tumor, Thymus Tumors Trial in France, Italy, Spain (177Lu-edotreotide, Everolimus)

Not yet recruiting
  • Neuroendocrine Tumors
  • +2 more
  • Bourdeaux, France
  • +24 more
Jun 23, 2023

Renal Failure Trial in Columbus (Everolimus, Sirolimus)

Completed
  • Renal Failure
  • Columbus, Ohio
    The Ohio State University Wexner Medical Center
Nov 2, 2021

Cutaneous Squamous Cell Carcinoma, Advanced Cancer Trial in Boston (Cemiplimab, Everolimus, Sirolimus)

Recruiting
  • Cutaneous Squamous Cell Carcinoma
  • Advanced Cancer
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 19, 2023

Thyroid Cancer Trial in Philadelphia (Lenvatinib, Everolimus)

Suspended
  • Thyroid Cancer
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Oct 7, 2021